Question of the Day – Thursday May 18, 2017
Question: What is the current usage level of illicit drugs by American youth?
Question of the Day – Wednesday May 17, 2017
Question: What are the potential advantages of buprenorphine as compared with morphine treatment of neonatal abstinence syndrome?
Question of the Day – Tuesday May 16, 2017
Question: What is the current status for use of the drug Rohypnol® in the United States?
Question of the Day – Monday May 15, 2017
Question: What is the historical significance of the drug aminorex?
Question of the Day – Thursday May 11, 2017
Question: What is endosulfan and what is the primary toxicity of this compound?
Question of the Day – Wednesday May 10, 2017
Question: Pulmonary toxicity is the most important dose limiting side effect of the chemotherapeutic agent bleomycin. What is the most common clinical presentation for patients with bleomycin pulmonary toxicity (BPT)?
Question of the Day – Tuesday May 9, 2017
Question: Hydroxychloroquine is commonly used in the treatment of a variety of rheumatologic diseases including lupus, and rheumatoid arthritis as well as for the treatment of certain malignancies (e.g. non-small cell lung cancer). What is the time course for the development of retinal toxicity in relation to the use of this drug?
Question of the Day – Monday, May 8 2017
Question: Which serious cutaneous disease resulted from the use of contaminated shaving brushes during the First World War and into the1920s?
Question of the Day – Friday May 5, 2017
Question: Under the Controlled Substances Act, what are the factors used to determine into which schedule a drug or substance should be placed or whether a substance should be decontrolled or rescheduled?5